{
    "clinical_study": {
        "@rank": "80410", 
        "arm_group": [
            {
                "arm_group_label": "Group A", 
                "description": "Subjects received 3 doses of the combination DTaP-HepB-IPV vaccine or separately administered DTaP, HepB, and IPV vaccines at 2, 4, and 6 months of age, in a previous study (217744/085)."
            }, 
            {
                "arm_group_label": "Group B", 
                "description": "Subjects received a single dose of the combination DTaP-IPV vaccine or separately administered DTaP and IPV vaccines at 4-6 years of age, in a previous study (213503/048)."
            }
        ], 
        "biospec_descr": {
            "textblock": "Serum"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "This study aims to analyse the serologic response to PCV-1 in the PEDIARIX\u00ae [GSK\n      Biologicals' Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B\n      (Recombinant) and Inactivated Poliovirus Vaccine] and KINRIX\u00ae (GSK Biologicals' Diphtheria\n      and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine)\n      vaccine products. The samples have been collected at pre-determined time points from a\n      subset of subjects who participated in selected studies [217744/085 and 213503/048]\n      conducted in the United States."
        }, 
        "brief_title": "Assessment of the Serologic Response to Porcine Circovirus Type 1 (PCV-1) in the Serum of Infants and Toddlers, Following Administration of IPV (Inactivated Poliovirus Vaccine)-Containing Vaccines", 
        "completion_date": {
            "#text": "May 2010", 
            "@type": "Actual"
        }, 
        "condition": "Presence of Materials From PCV-1", 
        "detailed_description": {
            "textblock": "Serum samples from the previously conducted clinical trials (217744/085 and 213503/048) are\n      used in this study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects enrolled previously in randomized, open and multicentre  studies\n             [217744/085; 213503/048].\n\n          -  Subjects aged 6 months to 6 years at last dose vaccinated with either DTaP-HepB-IPV\n             vaccine or separately administered DTaP, HepB, and IPV vaccines or DTaP-IPV vaccine\n             or separately administered DTaP and IPV vaccines.\n\n          -  Subjects for whom sufficient residual volume of the pre and post vaccination blood\n             samples is available.\n\n        Exclusion Criteria:\n\n          -  Not Applicable"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "6 Years", 
            "minimum_age": "2 Months", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Infants aged 2 and 6 months who were previously given a primary vaccination series\n        consisting of a single dose of combination DTaP-HepB-IPV (PEDIARIX\u00ae) vaccine at 2, 4, and\n        6 months of age or separately administered DTaP (INFANRIX\u00ae), HepB (ENGERIX-B\u00ae), and IPV\n        (Sanofi-Pasteur's IPOL) vaccines in the study 217744/085 and toddlers aged 4-6 years who\n        were previously vaccinated with a single dose of either the combination DTaP-IPV (KINRIX\u00ae)\n        vaccine or separately administered DTaP and IPV vaccines in the study 213503/048."
            }
        }, 
        "enrollment": {
            "#text": "1", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 12, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01651247", 
            "org_study_id": "114535", 
            "secondary_id": [
                "213503/048", 
                "217744/085"
            ]
        }, 
        "intervention": {
            "arm_group_label": [
                "Group A", 
                "Group B"
            ], 
            "description": "Serum samples collected at pre-determined time points in previously completed studies (217744/085 and 213503/048) will be analysed to detect the presence of anti PCV-1 antibodies.", 
            "intervention_name": "Serum sample", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Toddlers", 
            "Retrospective", 
            "Porcine circovirus type 1 (PCV-1)", 
            "Infants", 
            "Laboratory evaluations", 
            "IPV"
        ], 
        "lastchanged_date": "July 24, 2012", 
        "number_of_groups": "2", 
        "official_title": "Blinded Retrospective Laboratory Evaluations to Assess the Serologic Response to Porcine Circovirus Type 1 (PCV-1) in the Serum of Infants Aged 2 and 6 Months and Toddlers Aged 4-6 Years Following Administration of GlaxoSmithKline (GSK) Biologicals' IPV-containing Vaccines", 
        "overall_official": {
            "affiliation": "GlaxoSmithKline", 
            "last_name": "GSK Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Presence of serum anti-PCV-1 antibody.", 
            "safety_issue": "No", 
            "time_frame": "At Day 0 and post vaccination time points (up to 1 month after vaccination)."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01651247"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "GlaxoSmithKline", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "GlaxoSmithKline", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2010", 
        "study_design": "Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "July 2012"
    }
}